PDS Biotechnology PDSB 0.00%↑ dropped 40% last week on the ASCO presentation after there were confusion around their confirmed/unconfirmed response rate. The company held a conference call where they reported:
14/34 (41.2%) had either a confirmed or unconfirmed ORR.
9/34 (26.5%) had a confirmed ORR.
The Company said that an objective response occurs when a patient ha…